The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China. (September 2022)
- Record Type:
- Journal Article
- Title:
- The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China. (September 2022)
- Main Title:
- The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China
- Authors:
- Huang, Wei
Fang, Zhixiong
Luo, Si
Lin, Sha
Xu, Lei
Yan, Bo
yang, Yang
Liu, Xuhui
Xia, Lu
Fan, Xiaoyong
Lu, Shuihua - Abstract:
- Highlights: Bacillus Calmette–Guérin (BCG) vaccination can reduce the infection rate of Mycobacterium tuberculosis (MTB). The protective effect of BCG can be maintained until college enrollment. The ESAT6-CFP10 skin test (ECST) may underestimate the protective effects of BCG. The protective effect of BCG is better among college freshmen from rural areas. Abstract: Objectives: In this study, we aimed to verify whether Bacillus Calmette–Guérin (BCG) can protect first-year college students against Mycobacterium tuberculosis (MTB) infection by the recombinant fusion protein ESAT6-CFP10 skin test (ECST) or the tuberculin skin test (TST). Methods: We conducted a cross-sectional study to assess risk factors for latent tuberculosis infection (LTBI). Vaccine effectiveness of BCG against LTBI, measured by ECST and TST separately, was assessed using multivariable logistic regression. Results: A total of 7351 college freshmen accepted ECST, whereas 7228 accepted TST. A total of 263 (3.58%) tested positive with ECST and 581 (8.04%) tested positive with TST. BCG was significantly associated with LTBI (ECST: adjusted odds ratio (aOR) = 0.26; 95% CI 0.09 to 0.73; TST: aOR = 0.25; 95% CI 0.13 to 0.49). The BCG protective effect on freshmen living in rural areas (ECST: aOR = 0.16; 95% CI 0.04 to 0.55; TST: aOR = 0.12; 95% CI 0.04 to 0.33) is better than that of freshmen living in cities (ECST: aOR = 0.53; 95% CI 0.07 to 4.03; TST: aOR = 0.44; 95% CI 0.17 to 1.16). Conclusions: ProtectionHighlights: Bacillus Calmette–Guérin (BCG) vaccination can reduce the infection rate of Mycobacterium tuberculosis (MTB). The protective effect of BCG can be maintained until college enrollment. The ESAT6-CFP10 skin test (ECST) may underestimate the protective effects of BCG. The protective effect of BCG is better among college freshmen from rural areas. Abstract: Objectives: In this study, we aimed to verify whether Bacillus Calmette–Guérin (BCG) can protect first-year college students against Mycobacterium tuberculosis (MTB) infection by the recombinant fusion protein ESAT6-CFP10 skin test (ECST) or the tuberculin skin test (TST). Methods: We conducted a cross-sectional study to assess risk factors for latent tuberculosis infection (LTBI). Vaccine effectiveness of BCG against LTBI, measured by ECST and TST separately, was assessed using multivariable logistic regression. Results: A total of 7351 college freshmen accepted ECST, whereas 7228 accepted TST. A total of 263 (3.58%) tested positive with ECST and 581 (8.04%) tested positive with TST. BCG was significantly associated with LTBI (ECST: adjusted odds ratio (aOR) = 0.26; 95% CI 0.09 to 0.73; TST: aOR = 0.25; 95% CI 0.13 to 0.49). The BCG protective effect on freshmen living in rural areas (ECST: aOR = 0.16; 95% CI 0.04 to 0.55; TST: aOR = 0.12; 95% CI 0.04 to 0.33) is better than that of freshmen living in cities (ECST: aOR = 0.53; 95% CI 0.07 to 4.03; TST: aOR = 0.44; 95% CI 0.17 to 1.16). Conclusions: Protection against LTBI was strongly associated with BCG vaccination. A novel skin test (ECST) may underestimate the protective effects of BCG in college freshmen. BCG has better protection in areas with a slightly higher incidence of LTBI. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 122(2022)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 122(2022)
- Issue Display:
- Volume 122, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 122
- Issue:
- 2022
- Issue Sort Value:
- 2022-0122-2022-0000
- Page Start:
- 321
- Page End:
- 326.2
- Publication Date:
- 2022-09
- Subjects:
- BCG vaccine -- Mycobacterium tuberculosis infection -- Vaccine effectiveness -- ECST -- TST
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2022.06.010 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23289.xml